{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:07:05Z","timestamp":1775822825957,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01400-4","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:33:38Z","timestamp":1772649218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of striatal and extrastriatal [18F]fluoroDOPA uptake by a Silicon Photomultiplier PET camera in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-713X","authenticated-orcid":false,"given":"Jacques","family":"Darcourt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Malick","family":"Koulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Schiazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Comte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"1400_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1212\/WNL.53.6.1212","volume":"53","author":"WD Brown","year":"1999","unstructured":"Brown WD, Taylor MD, Roberts AD, Oakes TR, Schueller MJ, Holden JE, et al. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology. 1999;53:1212\u201318.","journal-title":"Neurology"},{"key":"1400_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0006-8993(03)02721-5","volume":"982","author":"RY Moore","year":"2003","unstructured":"Moore RY, Whone AL, McGowan S, Brooks DJ. Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study. Brain Res. 2003;982:137\u201345.","journal-title":"Brain Res"},{"issue":"Pt9","key":"1400_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/brain\/122.9.1637","volume":"122","author":"JS Rakshi","year":"1999","unstructured":"Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson\u2019s disease A 3D [(18)F]dopa-PET study. Brain. 1999;122(Pt9):1637\u201350.","journal-title":"Brain"},{"key":"1400_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1600-079X.2001.300404.x","volume":"30","author":"M Ghaemi","year":"2001","unstructured":"Ghaemi M, Rudolf J, Hilker R, Herholz K, Heiss WD. Increased pineal Fdopa uptake is related to severity of Parkinson\u2019s disease-a PET study. J Pineal Res. 2001;30:213\u20139.","journal-title":"J Pineal Res"},{"key":"1400_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ. Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis. 2008;29:381\u201390.","journal-title":"Neurobiol Dis"},{"key":"1400_CR6","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1088\/0031-9155\/45\/9\/313","volume":"45","author":"TJ Spinks","year":"2000","unstructured":"Spinks TJ, Jones T, Bloomfield PM, Bailey DL, Miller M, Hogg D, et al. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys Med Biol. 2000;45:2601\u201318.","journal-title":"Phys Med Biol"},{"key":"1400_CR7","first-page":"355","volume":"58","author":"J Darcourt","year":"2014","unstructured":"Darcourt J, Schiazza A, Sapin N, Dufour M, Ouvrier MJ, Benisvy D, et al. 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q J Nucl Med Mol Imaging. 2014;58:355\u201365.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1400_CR8","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","volume":"47","author":"S Morbelli","year":"2020","unstructured":"Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, et al. EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020;47:1885\u2013912.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1400_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/mds.870100302","volume":"10","author":"J Opacka-Juffry","year":"1995","unstructured":"Opacka-Juffry J, Brooks DJ. L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles. Mov Disord. 1995;10:241\u20139.","journal-title":"Mov Disord"},{"issue":"2","key":"1400_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12149-016-1143-2","volume":"31","author":"G Akamatsu","year":"2017","unstructured":"Akamatsu G, Ohnishi A, Aita K, Nishida H, Ikari Y, Sasaki M, et al. A revisit to quantitative PET with (18)F-FDOPA of high specific activity using a high-resolution condition in view of application to regenerative therapy. Ann Nucl Med. 2017;31(2):163\u201371.","journal-title":"Ann Nucl Med"},{"key":"1400_CR11","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1097\/RLU.0000000000002742","volume":"45","author":"P Decazes","year":"2020","unstructured":"Decazes P, Hapdey S, Humbert O, Marie-Cardine A, Vera P. Uptake of Pineal Gland Visible on 18F-DOPA PET\/CT With Last Generation of SiPM PET\/CT. Clin Nucl Med. 2020;45:e67\u20138.","journal-title":"Clin Nucl Med"},{"key":"1400_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1212\/WNL.0b013e31823fcdee","volume":"78","author":"EE Benarroch","year":"2012","unstructured":"Benarroch EE. Periaqueductal gray: an interface for behavioral control. Neurology. 2012;78:210\u20137.","journal-title":"Neurology"},{"key":"1400_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pneurobio.2019.02.001","volume":"177","author":"C Silva","year":"2019","unstructured":"Silva C, McNaughton N. Are periaqueductal gray and dorsal raphe the foundation of appetitive and aversive control? A comprehensive review. Prog Neurobiol. 2019;177:33\u201372.","journal-title":"Prog Neurobiol"},{"key":"1400_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33:75\u201387.","journal-title":"Mov Disord"},{"key":"1400_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"1400_CR16","doi-asserted-by":"publisher","first-page":"102161","DOI":"10.1016\/j.nicl.2019.102161","volume":"25","author":"GN Stormezand","year":"2020","unstructured":"Stormezand GN, Chaves LT, V\u00e1llez Garc\u00eda D, Doorduin J, De Jong BM, Leenders KL, et al. Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders. Neuroimage Clin. 2020;25:102161.","journal-title":"Neuroimage Clin"},{"key":"1400_CR17","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/j.1471-4159.1972.tb05099.x","volume":"19","author":"KG Lloyd","year":"1972","unstructured":"Lloyd KG, Hornykiewicz O. Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem. 1972;19:1549\u201359.","journal-title":"J Neurochem"},{"key":"1400_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuroimage.2015.04.065","volume":"116","author":"V Beliveau","year":"2015","unstructured":"Beliveau V, Svarer C, Frokjaer VG, Knudsen GM, Greve DN, Fisher PM. Functional connectivity of the dorsal and median raphe nuclei at rest. NeuroImage. 2015;116:187\u201395.","journal-title":"NeuroImage"},{"key":"1400_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuroimage.2016.03.019","volume":"133","author":"P Fazio","year":"2016","unstructured":"Fazio P, Schain M, Varn\u00e4s K, Halldin C, Farde L, Varrone A. Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data. NeuroImage. 2016;133:313\u201320.","journal-title":"NeuroImage"},{"key":"1400_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00259-012-2260-3","volume":"40","author":"M Schain","year":"2013","unstructured":"Schain M, T\u00f3th M, Csel\u00e9nyi Z, Arakawa R, Halldin C, Farde L, et al. Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT. Eur J Nucl Med Mol Imaging. 2013;40:228\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1400_CR21","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1002\/hbm.22855","volume":"36","author":"M Ezra","year":"2015","unstructured":"Ezra M, Faull OK, Jbabdi S, Pattinson KT. Connectivity-based segmentation of the periaqueductal gray matter in human with brainstem optimized diffusion MRI. Hum Brain Mapp. 2015;36:3459\u201371.","journal-title":"Hum Brain Mapp"},{"key":"1400_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.neuroimage.2009.05.017","volume":"47","author":"RA Menke","year":"2009","unstructured":"Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, Matthews PM, et al. MRI characteristics of the substantia nigra in Parkinson\u2019s disease: a combined quantitative T1 and DTI study. NeuroImage. 2009;47:435\u201341.","journal-title":"NeuroImage"},{"key":"1400_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1055\/s-0037-1608845","volume":"37","author":"JM Baker","year":"2017","unstructured":"Baker JM, Hung AY. Movement Disorders in Women. Semin Neurol. 2017;37:653\u201360.","journal-title":"Semin Neurol"},{"key":"1400_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/WCO.0000000000001071","volume":"35","author":"AWG Buijink","year":"2022","unstructured":"Buijink AWG, van Rootselaar AF, Helmich RC. Connecting tremors - a circuits perspective. Curr Opin Neurol. 2022;35:518\u201324.","journal-title":"Curr Opin Neurol"},{"key":"1400_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.nicl.2014.05.003","volume":"5","author":"S Sharifi","year":"2014","unstructured":"Sharifi S, Nederveen AJ, Booij J, van Rootselaar AF. Neuroimaging essentials in essential tremor: a systematic review. Neuroimage Clin. 2014;5:217\u201331.","journal-title":"Neuroimage Clin"},{"key":"1400_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ana.410280412","volume":"28","author":"DJ Brooks","year":"1990","unstructured":"Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol. 1990;28:547\u201355.","journal-title":"Ann Neurol"},{"key":"1400_CR27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s00259-015-3039-0","volume":"42","author":"A Picco","year":"2015","unstructured":"Picco A, Morbelli S, Piccardo A, Arnaldi D, Girtler N, Brugnolo A, et al. Brain (18)F-DOPA PET and cognition in de novo Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2015;42:1062\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1400_CR28","doi-asserted-by":"publisher","first-page":"e20629","DOI":"10.1016\/j.neurobiolaging.2010.09.004","volume":"33","author":"C Polito","year":"2012","unstructured":"Polito C, Berti V, Ramat S, Vanzi E, De Cristofaro MT, Pellican\u00f2 G, et al. Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson\u2019s disease. Neurobiol Aging. 2012;33:e20629\u201339.","journal-title":"Neurobiol Aging"},{"key":"1400_CR29","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.3390\/ijms24065683","volume":"24","author":"S Hazut Krauthammer","year":"2023","unstructured":"Hazut Krauthammer S, Cohen D, Even-Sapir E, Lerman H. Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on (18)F-DOPA PET\/CT? Int J Mol Sci. 2023;24:5683\u201311.","journal-title":"Int J Mol Sci"},{"key":"1400_CR30","unstructured":"Arendt J, Aulinas A. Physiology of the Pineal Gland and Melatonin. In: Feingold KR, Anawalt B, Boyce A, et al. editors. Endotext. South Dartmouth (MA). MDText.com, Inc.; 2000."},{"key":"1400_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/00207454.2019.1692838","volume":"130","author":"S Patel","year":"2020","unstructured":"Patel S, Rahmani B, Gandhi J, Seyam O, Joshi G, Reid I, et al. Revisiting the pineal gland: a review of calcification, masses, precocious puberty, and melatonin functions. Int J Neurosci. 2020;130:464\u201375.","journal-title":"Int J Neurosci"},{"key":"1400_CR32","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1016\/j.neuroimage.2009.11.035","volume":"49","author":"Y Kumakura","year":"2010","unstructured":"Kumakura Y, Danielsen EH, Gjedde A, Vernaleken I, Buchholz HG, Heinz A, et al. Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson\u2019s disease. NeuroImage. 2010;49:2933\u20139.","journal-title":"NeuroImage"},{"key":"1400_CR33","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.neuroimage.2011.09.034","volume":"59","author":"N Pavese","year":"2012","unstructured":"Pavese N, Simpson BS, Metta V, Ramlackhansingh A, Chaudhuri KR, Brooks DJ. [\u00b9\u2078F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [\u00b9\u2078F]FDOPA and [\u00b9\u00b9C]DASB PET study in Parkinson\u2019s disease. NeuroImage. 2012;59:1080\u20134.","journal-title":"NeuroImage"},{"issue":"Suppl 2","key":"1400_CR34","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.parkreldis.2008.04.021","volume":"14","author":"M Carta","year":"2008","unstructured":"Carta M, Carlsson T, Mu\u00f1oz A, Kirik D, Bj\u00f6rklund A. Involvement of the serotonin system in L-dopa-induced dyskinesias. Parkinsonism Relat Disord. 2008;14(Suppl 2):S154\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1400_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ijms21010294","volume":"21","author":"A Chagraoui","year":"2019","unstructured":"Chagraoui A, Boulain M, Juvin L, Anouar Y, Barri\u00e8re G, Deurwaerd\u00e8re P. L-DOPA in Parkinson\u2019s Disease: Looking at the False Neurotransmitters and Their Meaning. Int J Mol Sci. 2019;21:294\u201323.","journal-title":"Int J Mol Sci"},{"key":"1400_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","volume":"40","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, et al. Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11\u00a0C-DASB PET study. Neurobiol Dis. 2010;40:216\u201321.","journal-title":"Neurobiol Dis"},{"issue":"Suppl 2","key":"1400_CR37","first-page":"S2","volume":"51","author":"O Hornykiewicz","year":"1998","unstructured":"Hornykiewicz O. Biochemical aspects of Parkinson\u2019s disease. Neurology. 1998;51(Suppl 2):S2\u20139.","journal-title":"Neurology"},{"key":"1400_CR38","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1074\/jbc.M109.054510","volume":"285","author":"EA Cartier","year":"2010","unstructured":"Cartier EA, Parra LA, Baust TB, Quiroz M, Salazar G, Faundez V, et al. A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles. J Biol Chem. 2010;285:1957\u201366.","journal-title":"J Biol Chem"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01400-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:25:23Z","timestamp":1775820323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01400-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01400-4","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance to the Helsinki ethical standards and receive approval by the Comit\u00e9 d\u2019Ethique de M\u00e9decine Nucl\u00e9aire IRB 2024-08. Participants gave consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Institutional consent form was used to obtain participants consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}